Physician profile
Aamia Leach
NPI 1083136576
$3,019.06
in general payments reported to CMS, 2019-2025
17 companies · $658 in 2025
The $658 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $556 · 2022: $634 · 2023: $724 · 2024: $447 · 2025: $658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,829.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $587.46 | 2021-2025 | Rukobia, Cabenuva, Dovato |
| Jazz Pharmaceuticals INC. | $285.07 | 2022-2024 | |
| Esperion Therapeutics, INC. | $246.56 | 2021 | |
| Gilead Sciences, INC. | $237.80 | 2023-2025 | Biktarvy |
| Teva Pharmaceuticals USA, INC. | $236.72 | 2022 | |
| Abbvie INC. | $214.63 | 2023 | |
| Incyte Corporation | $205.72 | 2021-2025 | Jakafi, Niktimvo |
| Janssen Biotech, INC. | $149.88 | 2025 | Talvey, Tecvayli, Darzalex |
| Dexcom, INC. | $130.30 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Biohaven Pharmaceutical Holding Company LTD. | $123.84 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $121.13 | 2023 | Livtencity |
| Corcept Therapeutics | $100.00 | 2024 | Korlym |
| Genzyme Corporation | $93.23 | 2023 | |
| Theratechnologies INC. | $86.81 | 2023 | Trogarzo |
| Bayer Healthcare Pharmaceuticals INC. | $85.43 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recordati_rare_diseases_inc. | $83.10 | 2021 | |
| Janssen Products, LP | $31.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aamia Leach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.